Catherwood B D, Deftos L J
Biomed Pharmacother. 1984;38(5):235-41.
Although radioimmunoassay (RIA) methods for calcitonin (CT) have been available for ten years, there remain problems in achieving high sensitivity, controlling plasma and other protein artifacts, and interpreting results in light of circulating CT heterogeneity and tumor products having CT-like immunoreactivity. The development of sensitive radioimmunoassays meeting these criteria remains challenging. We will review some of the approaches to these problems.
尽管用于降钙素(CT)的放射免疫测定(RIA)方法已经存在了十年,但在实现高灵敏度、控制血浆和其他蛋白质假象以及根据循环CT异质性和具有CT样免疫反应性的肿瘤产物来解释结果方面仍然存在问题。开发符合这些标准的灵敏放射免疫测定法仍然具有挑战性。我们将回顾解决这些问题的一些方法。